Cancer Risk in Patients with Rheumatoid Arthritis Receiving Biologic and Targeted Synthetic Disease Modifying Antirheumatic Drugs: Data from a Multicenter National Real-World Registry
24/11/2025
Molina J et al.
https://scientific.sparx-ip.net/archiveeular/?c=a&searchfor=biobadaser&view=1&item=2025OP0065
EULAR 2025